NOV
NOV Inc.
Latest News for NOV
In a report released on December 15, David Evans from Kepler Capital maintained a Buy rating on Novo Nordisk, with a price target of DKK430.00. The......
In a report released today, from Freedom Capital Markets initiated coverage with a Buy rating on Enovis and a price target of $45.00. The word on T......
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Pfizer (PFE – Research Report) and Novan (NOVN – Res......
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Pfizer (PFE – Research Report), Novan (NOVN – Rese......
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Ligand Pharma (LGND – Research Report), MiMedx Group......
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Edwards Lifesciences (EW – Research Report), Novan (......
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Novan (NOVN – Research Report) and Tecan Group AG (TCHBF – Resear......
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Boston Scientific (BSX – Research Report), TransMedi......
In a report released today, Emmanuel Papadakis from Deutsche Bank maintained a Buy rating on Novartis AG, with a price target of CHF120.00. Papadak......
Deutsche Bank analyst Emmanuel Papadakis maintained a Buy rating on Novo Nordisk today and set a price target of DKK475.00. Papadakis covers the He......
News data is sourced from MarketXLS API and updated regularly.
Showing 10 of 51 articles.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | NOV | $15.40 | -5.2% | 2.66M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |